The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be
| Study Name on ClinicalTrials.gov (link is external) | A Longitudinal Study on the Impact of Treatment With ELX/TEZ/IVA in the Real World on Patients With Cystic Fibrosis in Europe |
|---|---|
| Study Drug | none/real world evidence trial |
| Type of Study Drug | - |
| Study Title | A Longitudinal Study on the Impact of Treatment With ELX/TEZ/IVA in the Real World on Patients With Cystic Fibrosis in Europe |
| Study Phase | IV |
| Study Sponsor | Vertex |
| Participating ECFS-CTN sites | Please contact ecfs-ctn@uzleuven.be for most recent sitelist |
| Age | Pediatric and Adult patients |